Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and ...

The medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare ...

Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...

AstraZeneca (AZ) and Merck – known as MSD outside the US and Canada – have shared positive results from a late-stage study of ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Next Wednesday, Rachel Reeves will deliver Labour’s first Budget in 15 years. As anticipation mounts on what will be included – and not included – I’ve taken some time to consider what measures are ...

GSK and Vesalius Therapeutics have entered into a strategic partnership worth $650m to discover and develop new treatments ...